Qualys, Inc. (NASDAQ:QLYS – Get Free Report) CFO Joo Mi Kim sold 1,627 shares of the business’s stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $100.17, for a total transaction of $162,976.59. Following the sale, the chief financial officer directly owned 83,211 shares in the company, valued at $8,335,245.87. This trade represents a 1.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Qualys Price Performance
Shares of QLYS opened at $102.37 on Friday. The firm has a market capitalization of $3.61 billion, a PE ratio of 18.38 and a beta of 0.58. Qualys, Inc. has a 1-year low of $74.51 and a 1-year high of $155.47. The company’s fifty day moving average price is $89.98 and its 200-day moving average price is $115.16.
Qualys (NASDAQ:QLYS – Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The software maker reported $1.95 earnings per share for the quarter, beating analysts’ consensus estimates of $1.81 by $0.14. The firm had revenue of $175.64 million for the quarter, compared to analyst estimates of $173.63 million. Qualys had a net margin of 29.41% and a return on equity of 37.15%. The business’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same period in the previous year, the company earned $1.67 earnings per share. Qualys has set its FY 2026 guidance at 7.440-7.650 EPS and its Q2 2026 guidance at 1.730-1.800 EPS. As a group, research analysts anticipate that Qualys, Inc. will post 5.47 EPS for the current fiscal year.
Institutional Investors Weigh In On Qualys
Analyst Ratings Changes
A number of brokerages have recently weighed in on QLYS. Wall Street Zen lowered shares of Qualys from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Piper Sandler decreased their target price on shares of Qualys from $135.00 to $100.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. Morgan Stanley set a $96.00 target price on shares of Qualys in a research report on Wednesday, May 6th. JPMorgan Chase & Co. decreased their target price on shares of Qualys from $113.00 to $87.00 and set an “underweight” rating for the company in a research report on Wednesday, May 6th. Finally, Royal Bank Of Canada boosted their target price on shares of Qualys from $85.00 to $90.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 6th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eleven have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $122.14.
View Our Latest Stock Analysis on QLYS
Qualys Company Profile
Qualys, Inc (NASDAQ: QLYS) is a leading provider of cloud-based security and compliance solutions designed to help organizations streamline their IT security programs. Operating on a unified, modular platform, Qualys offers continuous visibility into global IT assets through a combination of lightweight cloud agents and on-premises scanner appliances. The platform supports an array of security and compliance use cases, enabling real-time detection of vulnerabilities, policy violations and misconfigurations across on-premises, cloud and hybrid environments.
The company’s flagship Qualys Cloud Platform delivers a suite of integrated applications, including vulnerability management, detection and response (VMDR), policy compliance, web application scanning, file integrity monitoring, asset inventory and container security.
Recommended Stories
- Five stocks we like better than Qualys
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Qualys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qualys and related companies with MarketBeat.com's FREE daily email newsletter.
